ESG News For Agenus Inc

PICI’s Early Career Researcher Awards equip the brightest and boldest investigators with funding and connections to propel the field of cancer immunotherapySince 2016, PICI’s Early Career Researchers program has awarded more than $22.5 million through 53 total awards to ascendant researchers, enabling them to accelerate their careers and conduct independent, cutting-edge cancer research that drives real impact

Collaboration Will Continue to Raise Awareness of the Galleri® Multi-Cancer Early Detection Test, a New Proactive Tool in Finding Cancer EarlierPortion of Galleri Classic Proceeds Will be Directed to Local Cancer-related Nonprofit Organizations Focused on Underserved Populations in the Coachella Valley

Initial Deployment Across South Africa to Support Self-testers with Medical Diagnostech’s COVID-19 Antigen Test

In partnership with the Chicago Department of Public Health, 5,000 at-home COVID-19 rapid antigen self-tests will be distributed to organizations in need

Deep Pharma Intelligence released a special report “5 High-impact Cancer Vaccine Platforms”, which profiles the ecosystem of cancer vaccines companies on the cutting-edge of the field, and identify research strategies and platforms for cancer vaccine development holding the greatest potential to lead to breakthrough innovations in the coming years. It delivers advanced market profiling, mind maps, information about companies, case studies, and SWOT analysis of technology platforms.This press rel

Expanded agreement brings the total number of COVID-19 vaccine doses to be supplied to the U.S. government for donation to one billionEffort contributes to companies’ pledge to deliver two billion COVID-19 vaccine doses to low- and middle-income countries by the end of 2022

Recap of CSR stories on Business Wire

Facedrive Inc. (“Facedrive”) (TSXV:FD), (OTCQX:FDVRF), a multi-faceted “people-and-planet first” tech ecosystem, is pleased to announce that as of July 27, 2021, Facedrive has launched a distribution, training and collection program for the Government of Canada’s COVID-19 rapid antigen tests for small and medium-sized organizations. This initiative, ultimately aimed at reducing the spread of COVID-19 and its variants and reopening the economy in a safe and responsible manner, will make COVID-19

The Melanoma Research Alliance, the largest non-profit funder of melanoma research, is proud to announce $8.1 million in funding for 34 new research awards. The awards, issued near the start of Melanoma Awareness Month, provide critical funding to address urgent unmet needs in melanoma.“COVID-19 has impacted so much, including research and clinical trials. This investment in melanoma research is needed now more than ever,” said MRA Board Chair and Co-Founder Debra Black. “We’re proud to support

Finalist round will judge for clinical validation in competition aimed at developing frequent, fast, affordable, and easy-to-use COVID-19 tests, easing global supply chain

Zach and Barbara Horowitz, Jody Horowitz Marsh and Gary Marsh join Stephen Meringoff and the Meringoff Family Foundation in paying tribute to the legacy of Ben and Beverly Horowitz

Zach and Barbara Horowitz, Jody Horowitz Marsh and Gary Marsh join Stephen Meringoff and the Meringoff Family Foundation in paying tribute to the legacy of Ben and Beverly Horowitz